Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33,235,472
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
18,012,051
-
Shares change
-
+534,349
-
Total reported value, excl. options
-
$181,543,000
-
Value change
-
+$1,949,052
-
Number of buys
-
19
-
Number of sells
-
-15
-
Price
-
$10.08
Significant Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q4 2021
45 filings reported holding NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share as of Q4 2021.
NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,012,051 shares
of 33,235,472 outstanding shares and own 54.2% of the company stock.
Largest 10 shareholders include KCK LTD. (5,621,111 shares), ORBIMED ADVISORS LLC (4,012,281 shares), Soleus Capital Management, L.P. (2,309,003 shares), FMR LLC (1,066,037 shares), Revelation Capital Management, LLC (666,540 shares), PICTET ASSET MANAGEMENT SA (560,444 shares), AMERICAN CENTURY COMPANIES INC (534,550 shares), Bellevue Group AG (507,930 shares), KORNITZER CAPITAL MANAGEMENT INC /KS (435,719 shares), and LORD, ABBETT & CO. LLC (355,972 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.